Spectrum Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Spectrum Pharmaceuticals

17/03/2022 21:01

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a
quarterly
adjusted loss of 26 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 21 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Spectrum Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 26 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Spectrum Pharmaceuticals Inc shares had fallen by 39.4%
this
quarter.
    * The company reported a quarterly loss of $39.71 million.
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 17 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated